We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$810M
AUM Growth
+$14.8M
(+1.9%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
267
New
10
Increased
152
Reduced
75
Closed
6
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Financials ETF
VFH
|
+$2.4M |
| 2 |
Vanguard Information Technology ETF
VGT
|
+$1.96M |
| 3 |
iShares Micro-Cap ETF
IWC
|
+$1.6M |
| 4 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$1.18M |
| 5 |
Comcast
CMCSA
|
+$1.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Reliance Steel & Aluminium
RS
|
+$2.93M |
| 2 |
Ubiquiti
UI
|
+$1.99M |
| 3 |
The Marzetti Company
MZTI
|
+$491K |
| 4 |
Vanguard Communication Services ETF
VOX
|
+$416K |
| 5 |
Novartis
NVS
|
+$411K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.85% |
| 2 | Healthcare | 14.41% |
| 3 | Consumer Staples | 14.22% |
| 4 | Technology | 11.2% |
| 5 | Financials | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Micron Technology
MU
$1.05T
| $184K | 0.02% |
17,578
-1,205
| -6% | -$13.5K |
2015 Q2
3 quarters
|
|
252
Actinium Pharmaceuticals
ATNM
$33.3M
| $46K | 0.01% |
762
| – | – |
2015 Q4
1 quarter
|
|
|
LQMT
253
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $22K | ﹤0.01% |
173,000
-40,000
| -19% | -$5.09K |
2013 Q2
11 quarters
|
|
254
iShares MSCI ACWI ex US ETF
ACWX
$17.5B
| – | – |
-8,500
| Closed | -$337K | – |
|
|
255
Novartis
NVS
$286B
| – | – |
-5,334
| Closed | -$411K | – |
|
|
256
Ubiquiti
UI
$37.4B
| – | – |
-62,920
| Closed | -$1.99M | – |
|
|
RDS.A
257
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-4,857
| Closed | -$211K | – |
|
|
UCFC
258
DELISTED
United Community Financial Corp
UCFC
| – | – |
-50,000
| Closed | -$295K | – |
|
259
DELISTED
Windtree Therapeutics Inc
WINT
| – | – |
-5,004
| Closed | -$15K | – |
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q1 2016 Portfolio in Review
As of Q1 2016, Dowling & Yahnke held 267 positions worth $810M, up 1.9% from $795M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Dowling & Yahnke's Q1 2016 filing shows 10 new, 152 increased, 75 reduced and 6 closed positions. Its largest new stake was Orexigen Therapeutics, Inc.: 68,381 shares worth $385K. The largest sale was Reliance Steel & Aluminium, an estimated $2.93M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Dowling & Yahnke's largest Q1 2016 buy was Orexigen Therapeutics, Inc.: 68,381 shares worth $385K.
- Dowling & Yahnke added most to Vanguard Financials ETF in Q1 2016, an estimated $2.4M increase.
- Dowling & Yahnke's biggest Q1 2016 reduction was Reliance Steel & Aluminium, cutting an estimated $2.93M.
- Dowling & Yahnke fully exited Ubiquiti in Q1 2016, selling an estimated $1.99M.
- Dowling & Yahnke's ten largest holdings make up 25% of its $810M portfolio in Q1 2016.
- Dowling & Yahnke opened 10 new positions and closed 6 in Q1 2016.
- Dowling & Yahnke's portfolio value rose 1.9% quarter-over-quarter to $810M.
Based on Dowling & Yahnke's 13F filing for Q1 2016, filed 28 Apr 2016.